Biological clocks could play an important role in helping to promote healthy ageing and to stem the growing incidence of age-related diseases by improving the quality of life of the aged, reducing mortality and relieving the burden on overwhelmed health and social care resources.
The health system and startup studio's new joint venture will develop and launch companies that use artificial intelligence to address healthcare problems, including disparities in care. The venture will combine Northwell's clinical expertise and patient data with Aegis' data scientists and commercialization capabilities.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Realyze Intelligence, incubated at and funded by UPMC Enterprises, provides a platform that uses EMR data to identify chronic disease patients and help clinicians link them to appropriate treatment options. The platform leverages not only the structured data available in EMRs but also unstructured clinical notes.
Developed by Noteworth, the ConnectedCare365 application will enable Geisinger clinicians to virtually monitor patient vital signs and intervene when needed. The platform will be used for several clinical initiatives, including chronic condition management and behavioral health.
A visit to the Louisiana health system sheds some light on how it is innovatively addressing chronic diseases like hypertension and diabetes, the inpatient experience and more.
PatientPoint will give patients and physicians AMA-developed educational material to help them identify the risks for the diseases and encourage them to take action.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
A recording on the company's main contact number noted that the health IT business was discontinued despite efforts to raise additional capital or find a strategic partner to enable the company to continue operations.